BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 3.49 billion as of May 15, 2025. Its market cap has decreased by -22.70% in one year.

Market Cap

3.49B

Enterprise Value

2.94B

Revenue

179.57M

Ranking

n/a

PE Ratio

n/a

Stock Price

28.15

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.49B, an increase of 28.64%. That is a compound annual growth rate of 4.35%.

Market Cap History

Date	Market Cap	% Change
May 15, 2025	3.50B	-16.34%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.19B
Caliway Biopharmaceuticals	115.80B
Bora Pharmaceuticals Co., LTD.	73.49B
Lotus Pharmaceutical	60.56B
Polaris Group	33.16B
Oneness Biotech	29.46B
Pegavision	27.14B
Lumosa Therapeutics	26.85B

Market Cap Rankings